Owner The Administrators of the Tulane Educational Fund

Inventors Sun, Lichun; Coy, David, H.; Murphy, William, A.; Fuselier, Joseph, A.

Agent Griffith Hack

Pub. Number AU-B-2002341792

PCT Number PCT/US02/30143

PCT Pub. Number WO2003/028527

Priority 60/323,851 21.09.01 US

Filing date 20 September 2002

Wipo publication date 14 April 2003

Acceptance publication date 6 September 2007

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61B 1/00 (2006.01) Diagnosis

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 31/4745 (2006.01)

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/10 (2006.01) Medicinal preparations containing peptides - Peptides having 12 to 20 amino acids

A61K 38/31 (2006.01) Medicinal preparations containing peptides - Somatostatins

A61K 47/42 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Proteins

A61K 49/00 (2006.01) Preparations for testing

A61K 51/00 (2006.01) Preparations containing radioactive substances for use in therapy or testing

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 13/08 (2006.01) Drugs for disorders of the urinary system

A61P 15/00 (2006.01) Drugs for genital or sexual disorders

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 27/02 (2006.01) Drugs for disorders of the senses

A61P 35/00 (2006.01) Antineoplastic agents

C07K 7/08 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 14/655 (2006.01) Peptides having more than 20 amino acids